Non-Invasive Positive Pressure Ventilation and Adult Respiratory Distress Syndrome (ARDS) (NPPV)
Acute Respiratory Distress Syndrome
About this trial
This is an interventional treatment trial for Acute Respiratory Distress Syndrome focused on measuring ARDS,, noninvasive ventilation,, intubation,, mortality,, intensive care
Eligibility Criteria
Inclusion Criteria:The following criteria indicated immediate intubation was needed:
- Apne or respiratory pauses with loss of consciousness or gasping for breath or imminent respiratory arrest.
- Inability to increase the patient's PaO2 to more than 40 mmHg and SpO2 to more than 80% with a FiO2>0.6.
- Inability to increase the patient's pH levels above 7.35, and development of blurred consciousness and confusion (Glasgow Coma Scale <9) due to respiratory acidosis despite all the support given.
- Instability of the patient's hemodynamic parameters (such as systolic blood pressure <80 mmHg or heart rate <50 beats/minute lasting >1 hour despite fluid resuscitation).
Exclusion Criteria:Contraindications for NPPV include:
- The need for urgent intubation.
- The need for frequent aspiration due to excessive secretions (more frequent than 15 min.).
- Inability of the patient to adapt himself / herself to the device or unwillingness to undergo NPPV.
Sites / Locations
- Eskisehir Osmangazi University, Medical Faculty,
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
1
2
ARDS patients in the NPPV group showing no indications for urgent intubation received NPPV in addition to standard medical therapy, and those with indications were intubated.
Patients in the standard therapy group without indications for urgent intubation were only given standard medical therapy (such as oxygen, antibiotics, and bronchodilators), and IMV through an endotracheal tube was applied when intubation criteria were met.